GlassScriptPhysician profile
Thomas Raymond Haley
NPI 1437288776
$11,857.53
in general payments reported to CMS, 2019-2025
47 companies · $2,283 in 2025
The $2,283 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,130 · 2020: $1,178 · 2021: $1,338 · 2022: $1,588 · 2023: $1,403 · 2024: $1,937 · 2025: $2,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,584 · Education: $39.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,583.92 |
| Education | $39.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,978.36 | 2019-2025 | Eterna, Proclaim, Octrode |
| Nevro Corp. | $921.89 | 2019-2024 | Vyrsa V1, Senza |
| Medtronic, INC. | $873.09 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Synchromedii |
| Vertos Medical, INC. | $846.42 | 2019-2024 | Mild Device Kit |
| Boston Scientific Corporation | $837.74 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Amgen INC. | $601.28 | 2019-2025 | Evenity, Prolia |
| Mml US, INC. | $575.03 | 2024-2025 | Reactiv8 |
| Averitas Pharma INC. | $463.06 | 2023-2025 | Qutenza |
| Tersera Therapeutics LLC | $455.13 | 2019-2025 | Prialt |
| Radius Health, INC. | $337.73 | 2019-2025 | Tymlos |
| Si-Bone, INC. | $295.66 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $283.77 | 2019-2025 | |
| Globus Medical, INC. | $247.13 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $188.82 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $176.84 | 2022-2025 | Relistor |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Haley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.